PortfoliosLab logo

Annovis Bio, Inc. (ANVS)

Equity · Currency in USD · Last updated Jan 31, 2023

Company Info

ISINUS03615A1088
CUSIP03615A108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$15.25
Year Range$8.61 - $21.81
EMA (50)$12.77
EMA (200)$12.80
Average Volume$34.51K
Market Capitalization$124.50M

ANVSShare Price Chart


Loading data...

ANVSPerformance

The chart shows the growth of $10,000 invested in Annovis Bio, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $17,956 for a total return of roughly 79.56%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2023
56.11%
-3.31%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ANVS

Annovis Bio, Inc.

ANVSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M28.22%4.64%
YTD28.22%4.64%
6M49.74%-2.72%
1Y25.79%-9.34%
5Y21.55%7.07%
10Y21.55%7.07%

ANVSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20221.41%0.87%18.10%-8.39%7.09%-0.07%

ANVSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Annovis Bio, Inc. Sharpe ratio is 0.35. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.200.40SeptemberOctoberNovemberDecember2023
0.35
-0.29
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSDividend History


Annovis Bio, Inc. doesn't pay dividends

ANVSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-85.77%
-16.24%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSWorst Drawdowns

The table below shows the maximum drawdowns of the Annovis Bio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Annovis Bio, Inc. is 92.88%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.88%Jul 14, 2021219May 24, 2022
-73.93%Jan 30, 202045Apr 2, 2020197Jan 13, 2021242
-43.94%Mar 18, 202133May 4, 202113May 21, 202146
-25.67%May 24, 20214May 27, 20214Jun 3, 20218
-25.05%Feb 23, 20219Mar 5, 20216Mar 15, 202115
-17.86%Jun 22, 20212Jun 23, 20217Jul 2, 20219
-13.29%Feb 5, 20211Feb 5, 20212Feb 9, 20213
-6.06%Jun 9, 20211Jun 9, 20211Jun 10, 20212
-5.95%Jan 27, 20211Jan 27, 20214Feb 2, 20215
-5.61%Jun 17, 20211Jun 17, 20212Jun 21, 20213

ANVSVolatility Chart

Current Annovis Bio, Inc. volatility is 93.66%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2023
93.66%
18.51%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)